Report
Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.
Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality.
To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would:
- better inform decisions and plans of those responsible for developing new cancer therapies
- more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic
- be less costly than current trials
The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward.
Other Reports by this Activity
Displaying: 3 of 8 Reports
-
Policy Issues in the Development of Personalized Medicine in Oncology. Workshop Summary
As cancer care becomes more personalized, patients will receive preventive or therapeutic interventions based on their susceptibilities or predicted responses. But before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of policy issues. To explore these policy challenges, the National Cancer Policy Forum held this workshop in June 2009.
Released: February 8, 2010
-
Assessing and Improving Value in Cancer Care. Workshop Summary
Like other areas of health care, oncology is under pressure to control expenses while improving patient outcomes and the quality of care. Unlike many other areas of health care, however, oncology faces unique challenges that can make it especially difficult to control costs. On February 9-10, 2009, the National Cancer Policy Forum held a workshop to explore these issues from multiple perspectives, including those of patients and patient advocates, providers, insurers, health care researchers, federal agencies, and industry. Assessing and Improving the Value in Cancer Care summarizes workshop discussions and presentations.
Released: November 4, 2009
-
Ensuring Quality Cancer Care through the Oncology Workforce: Sustaining Care in the 21st Century. Workshop Summary
The American Society of Clinical Oncology (ASCO) predicts that by 2020, there will be an 81 percent increase in people living with or surviving cancer but only a 14 percent increase in the number of practicing oncologists. As a result, there may be too few oncologists to meet the population’s need for cancer care. To help address the challenges in overcoming this potential crisis of cancer care, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened the workshop “Ensuring Quality Cancer Care through the Oncology Workforce: Sustaining Care in the 21st Century” in Washington, DC on October 20 and 21, 2008.
Released: April 24, 2009
Future Meeting for this Activity
View Agenda
Previous Meeting for this Activity